Extrel CMS

Extrel CMS is a leading manufacturer of high-performance quadrupole mass spectrometers and components for research and industrial applications. Founded in 1964, the company provides advanced analytical solutions for gas analysis, surface science, and core mass spectrometry research, supporting sectors such as pharmaceuticals, biotechnology, and environmental monitoring. Their product portfolio includes laboratory systems, process gas analyzers, and specialized components for atmospheric and space research. Extrel's technology is widely utilized in drug discovery, metabolomics, and clinical diagnostics to provide precise molecular identification and quantification. In 2023, the company was acquired by Process Insights, a portfolio company of Union Park Capital, to enhance its global analytical capabilities.